Home>>ADB-PINACA N-(4-hydroxypentyl) metabolite

ADB-PINACA N-(4-hydroxypentyl) metabolite

Catalog No.GC41179

ADB-PINACA is an analog of AKB48, a synthetic cannabinoid also known as APINACA.

Products are for research use only. Not for human use. We do not sell to patients.

ADB-PINACA N-(4-hydroxypentyl) metabolite Chemical Structure

Size Price Stock Qty
1mg
$163.00
In stock
5mg
$385.00
In stock
10mg
$599.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ADB-PINACA is an analog of AKB48 , a synthetic cannabinoid also known as APINACA. ADB-PINACA N-(4-hydroxypentyl) metabolite is an expected phase 1 metabolite of ADB-PINACA, based on the known metabolism of similar compounds.[1] [2] The physiological properties of this compound have not been evaluated. This product is intended for forensic and research applications.

Reference:
[1]. Zhang, Q., Ma, P., Cole, R.B., et al. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Analytical and Bioanalytical Chemistry 386, 1345-1355 (2006).
[2]. Wintermeyer, A., Möller, I., Thevis, M., et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal. Bioanal. Chem. 398(5), 2141-2153 (2010).

Reviews

Review for ADB-PINACA N-(4-hydroxypentyl) metabolite

Average Rating: 5 ★★★★★ (Based on Reviews and 14 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ADB-PINACA N-(4-hydroxypentyl) metabolite

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.